Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19

Raymund R. Razonable, Colin Pawlowski, John C. O'Horo, Lori L. Arndt, Richard Arndt, Dennis M. Bierle, Molly Destro Borgen, Sara N. Hanson, Michelle C. Hedin, Patrick Lenehan, Arjun Puranik, Maria T. Seville, Leigh L. Speicher, Sidna M. Tulledge-Scheitel, A. J. Venkatakrishnan, Caroline G. Wilker, Andrew D. Badley, Ravindra Ganesh

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19'. Together they form a unique fingerprint.

Medicine & Life Sciences